Keyphrases
Poly(ADP-ribose) Polymerase
100%
Diabetic Endothelial Dysfunction
100%
High Glucose
33%
Vascular Reactivity
16%
Endothelial Dysfunction
16%
Diabetes
16%
Hyperglycemia
16%
Reactive Oxygen Species
16%
Endothelial Cells
16%
Novel Therapeutic Targets
16%
Streptozotocin
16%
PARP Inhibitor (PARPi)
16%
Islet Cells
16%
DNA Double-strand Breaks
16%
Nuclear factor-B
16%
Reactive Nitrogen Species
16%
Neuropathy
16%
Diabetic Patients
16%
Nephropathy
16%
Retinopathy
16%
Endothelium-dependent Vasodilation
16%
Endothelial Function
16%
Islet
16%
Severe Hyperglycemia
16%
Functional Impairment
16%
Vascular Alterations
16%
DNA Breakage
16%
Basal Glucose
16%
Accelerated Atherosclerosis
16%
Metabolic Impairment
16%
Medicine and Dentistry
Endothelial Dysfunction
100%
Poly ADP Ribose Polymerase
100%
Hyperglycemia
33%
Diabetes
16%
Reactive Oxygen Species
16%
Atherosclerosis
16%
Endothelial Cell
16%
Oxidizing Agent
16%
Streptozocin
16%
PARP Inhibitor
16%
DNA Strand Breakage
16%
Reactive Nitrogen Species
16%
Nephropathy
16%
Nuclear Factor
16%
Retinopathy
16%
Neuropathy
16%
Endothelial Function
16%
Vasodilatation
16%
Functional Disease
16%
Alternative Complement Pathway C3 C5 Convertase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Endothelial Dysfunction
100%
Hyperglycemia
33%
Reactive Oxygen Metabolite
16%
Atherosclerosis
16%
Kidney Disease
16%
Nuclear Factor
16%
Streptozotocin
16%
Oxidizing Agent
16%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
16%
Alternative Complement Pathway C3 C5 Convertase
16%
Neuropathy
16%
Retinopathy
16%
Functional Disease
16%
Immunology and Microbiology
Atherosclerosis
100%
DNA Strand Breakage
100%
Complement Factor B
100%
Vasodilatation
100%
Biochemistry, Genetics and Molecular Biology
Poly ADP Ribose Polymerase
100%
Hyperglycemia
28%
DNA Strand Breakage
14%
Streptozotocin
14%
Vasodilatation
14%
Complement Factor B
14%
Reactive Nitrogen
14%